For most of us, a cancer diagnosis would be the worst possible news. But a remarkable new documentary, Second Winds, captures ...
A short film that premiered earlier this month tracks the journeys of three people who discovered a renewed commitment to ...
A phase 2 study reveals high efficacy and manageable safety of venetoclax plus obinutuzumab for untreated CLL/SLL in Japanese ...
What study showed data for zanubrutinib in previously untreated CLL? Mazyar Shadman, MD, MPH: The SEQUOIA study was a larger ...
AbbVie (NYSE: ABBV) announced today the launch of Second Winds, a new short film that captures the powerful, deeply personal journeys of three people living with chronic lymphoma leukemia (CLL), a ...
FITBOOK magazine on MSN
Signs That May Indicate Blood Cancer
The term leukemia, colloquially known as blood cancer, is already familiar to most people. No wonder—in Germany, around ...
Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing ...
Transitioning from marathon running to walking and weight training reflects adaptability and finding joy in diverse physical ...
Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—a leading research partner of the NCI-designated ...
President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including ...
(GLOBE NEWSWIRE) -- (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global, commercial stage, ...
The world-renowned, peer-reviewed, open-access Nature journal, Signal Transduction and Targeted Therapy, publishes original ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback